Sonata Therapeutics

Sonata Therapeutics is revolutionizing the world's understanding of the cellular microenvironment and its importance to human biology and disease. Sonata Therapeutics’ product platform is based on the systematic and comprehensive characterization of the microenvironment in diseases with high unmet medical needs to develop drugs. Through its groundbreaking science, Sonata Therapeutics identifies new therapeutic targets, induces the release of programmed signaling diversity, and drives therapeutic microenvironments. Sonata is developing an increasing number of small molecule drugs and gene therapies, including preclinical programs targeting a wide range of tumor indications, as well as exploratory efforts in fibrosis and autoimmune diseases.